Tables
- TABLE 1
General characteristics of the participants included in the randomised controlled trials assessing the effects of continuous positive airway pressure (CPAP) treatment on cardiovascular morbimortality
SAVE study [12] RICCADSA study [13] ISAACC study [15] Inclusion criteria Moderate-severe OSA (ODI ≥12 events·h−1) Moderate-severe OSA (AHI ≥15 events·h−1) Moderate-severe OSA (AHI ≥15 events·h−1) Coronary artery disease or cerebrovascular disease Coronary artery disease Acute coronary syndrome Exclusion criteria Severe daytime sleepiness (ESS >15/24) Excessive daytime sleepiness (ESS ≥10/24) Excessive daytime sleepiness (ESS >10/24) Age, years 61 66 60 Men, % 81 85 84 ESS 7.4 5.5 5.2 AHI, events·h−1 31 29 36 Number of events, n (%) CPAP: 229 (17%) CPAP: 22 (18%) CPAP: 98 (16%) Usual care: 207 (15%) Usual care: 27 (22%) Usual care: 108 (17%) CPAP use, mean±sd, h per night 3.3±2.3 Not stated 2.8±2.7 Age, ESS, AHI are presented as the mean values for the study cohort. AHI: apnoea–hypopnoea index; ESS: Epworth sleepiness scale; ODI: oxygen desaturation index; OSA: obstructive sleep apnoea.